Podcasts about Atrium Health

Britney Broyhill, DNP, ACNP-BC, FAANP, is the Senior Director of Advanced Practice for Atrium Health.Thanks for tuning in! Check out more episodes of The Well-Being Connector at www.bethejoy.org/podcast.

In this episode of The Best of LKN podcast, Jeff interviews Dr. Kenesha Kirkland and Dr. Christopher Messitt from Atrium Health Concierge Care in Cornelius. They discuss the innovative concierge care model, which allows for a more personalized and accessible healthcare experience. The conversation covers the inspiration behind the practice and the holistic approach to patient care that emphasizes prevention and individualized treatment plans. The doctors also share their excitement about expanding services to the Lake Norman area and the future of concierge care in the community.Atrium Health Concierge Care Lake Norman9623 Bailey Rd #220Cornelius, NC 28031(704) 801-8330---------------------------------------------------------------------------------------The Best of LKNhttps://thebestoflkn.com/Hosted by:Jeff HammReal Estate BrokerCharlotte & Lake Norman (NC)https://lknreal.com/Support the show

The average American family spends over $24,000 a year on healthcare, and costs continue to rise faster than inflation. Why can't we create a healthcare system that delivers more value for less money?In this conversation with Ann Somers Hogg, Director of Healthcare Research at the Clayton Christensen Institute, we explore the concept of "Zero Inflation Healthcare" and uncover why traditional health insurance models continue to drive costs up. Ann breaks down why many InsureTech startups initially struggled to disrupt incumbents and how a new approach to business model innovation could finally tame runaway healthcare costs.We cover:

In episode 16 of Constructing with Care, we dig into how prefabrication is driving tangible financial benefits, improving safety, and accelerating speed to market for healthcare construction projects. Industry leaders join the conversation to break down the power of standardization, long-term operational savings, and the importance of reducing variation in care environments. Hear real-world examples from healthcare systems and learn how cash flows and standardizing processes can support both the bottom line and community care. Guest: Sean Ashcroft, Healthcare Core Market Leader, DPR Construction   Guest: Jeff Schroder, AVP Planning, Design and Construction, Atrium Health, part of Advocate Health   Guest: Sarah Francis - Enterprise Assistant Vice President, Standards & Activation-Planning, Design & Construction, Advocate Health   Key Takeaways [5:20] – Setting the Stage: Financial Pressures + Tech Investments Host Leslie kicks off the conversation by exploring how prefab can address rising financial pressures for healthcare systems while supporting aggressive tech investments. [6:20] – Two Big Wins from Prefab (Sean) Sean highlights the long-term flexibility and operational uptime of prefab systems, plus how prefab impacts critical path scheduling to generate revenue faster. [7:12] – Hospital Perspective: Managing Cashflow at Scale (Jeff) Jeff dives into Atrium Health's approach to managing billions in active projects, explaining how prefab helps front-load purchases and reduce variation and risk from supply chain disruptions and tariffs. [9:17] – Standardization at the Enterprise Level (Sarah) Sarah underscores the importance of minimizing variation across builds, enabling process improvement and better data insights. Standardization is key to long-term efficiency. [10:12] – Compounding Effects of Eliminating Variation Sean expands on how standardization and prefab eliminate variation early—helping avoid rework and driving downstream time and cost savings.   Quotes Jeff Schroder, AVP Planning, Design and Construction, Atrium Health, part of Advocate Health   "Prefabrication helps us mitigate unpredictable factors like weather, labor shortages, and tariffs." Sarah Francis, Enterprise Assistant Vice President, Standards & Activation-Planning, Design & Construction, Advocate Health   "To ensure long-term efficiency we need to focus on minimizing variation, keeping a standardized approach that also allows us to measure and have data."  Sean Ashcroft, Healthcare Core Market Leader, DPR Construction   "There's a necessity for early engagement and ensuring the whole team understands the logic behind prefabrication to avoid gaps in execution."   

Conflict is a natural part of life, but it doesn't have to be negative. In this episode of the SMFM Podcast Series, Dr. Rachel Harrison sits down with Dr. Ngina Connors, OB/GYN Chair at Atrium Health and Vice Chair of SMFM's Practice Management Committee, to explore strategies for effective conflict resolution. They discuss the different types of conflict that arise in maternal-fetal medicine, from interpersonal disagreements to team dynamics on labor and delivery. Dr. Connors shares insights on fostering open dialogue, managing workplace conflicts, and approaching difficult conversations with patients and colleagues. They also provides practical techniques, including the power of active listening and the “7-second rule,” to help de-escalate tensions and build stronger, more collaborative teams. Listen now and explore additional resources from SMFM at education.smfm.org. Practice Management Virtual Course  Click here for the full episode transcript. 

In this episode, Collin Lane, Senior Vice President of Ancillary, Shared Services, and Facilities Management at Atrium Health, discusses the transformative 1.1 million square foot advanced care facility at Atrium Health Carolinas Medical Center. Learn how this project addresses aging infrastructure, growing demand, and the future of healthcare delivery with innovative design, prefabrication, and cutting-edge technologies to meet the needs of a rapidly evolving market.

Dr Anthony Holden, Thoracic Cardiovascular Surgeon at Atrium Health discusses a robotic biopsy procedure to examine tumors in the lung to detect the presence of cancer. It is highly recommended for current and ex smokers and individuals who have lung problems.

Accurate urine output monitoring is crucial for early detection and management of acute kidney injury. In this episode, Tom Calabro, Assistant Vice President of Cardiac Service Line for Atrium Health, discusses the importance of automated urine collection systems in today's fast-paced, data-driven healthcare environment, particularly concerning AKI. He explains AKI, its causes, and how it is categorized into pre-renal, intrinsic, and post-renal phases. Tom highlights the significance of urine output as an early indicator of AKI, emphasizing its role in timely intervention and improved patient outcomes, even amidst nursing shortages. He also shares his experience with the Akron automated urine collection system, praising its accuracy, EMR integration, ability to predict AKI onset up to 30 hours earlier, and overall contribution to enhanced patient care.  Tune in and learn how automated urine output monitoring can empower nurses, improve patient safety, and ultimately save lives! Resources: Connect with and follow Tom Calabro on LinkedIn. Follow Atrium Health on LinkedIn and explore their website.

Irene Bolis, Administrative Clinic Director for Outpatient Neurology at Atrium Health, discusses innovative recruitment strategies within the healthcare sector. She highlights how data-driven approaches are leveraged to identify top candidates, ensuring they align with Atrium Health's values and goals. Bolis also emphasizes the importance of nurturing employee growth through mentorship programs, fostering continuous learning and professional development. Her insights underscore a commitment to creating a supportive work environment that cultivates both talent acquisition and retention.

Four pharmacist entrepreneurs share their journeys from pharmacy to thriving businesses, offering tips, actionable advice and inspiration. This episode is brought to you by APhA. Summary In this engaging panel discussion, four pharmacist entrepreneurs—Brooke Griffin, Jimmy Pruitt III, Kelley Carlstrom, and Natalie Park—share their unique paths from pharmacy to thriving businesses. Discover how they built their ventures, made strategic decisions, and overcame challenges along the way. Gain practical insights into audience building, pricing strategies, navigating sales, and balancing personal and professional growth.  Whether you're dreaming up a new idea or ready to expand your business, this episode is packed with actionable advice and inspiration to help you take the next step in your entrepreneurial journey. About Today's Guests Kelley Carlstrom is the CEO and founder of KelleyCPharmD, an education company that fills the considerable gap in clinical oncology training. She is passionate about democratizing oncology pharmacy education and increasing accessibility and inclusion through her unique L.E.A.R.N Oncology Method. Brooke Griffin is a pharmacist, professor, keynote speaker, and professional coach. She offers group and 1:1 coaching for pharmacists who are feeling stuck and want clarity on their next steps. She hosts a motivational 5-minute podcast, Today's Bold Idea, and is on this self-discovery journey alongside all of you. She believes everyone deserves a coach! Dr. Natalie Park is a co-founder and CEO of Pharmesol, an AI pharmacy assistant that automates inbound/outbound calls, messages, and associated workflows such as documentation to save the pharmacy teams time, streamlines operations, and gives 24/7 concierge-like experience for their customers. She is a pharmacist with a passion for leveraging technology and innovation in the pharmacy industry. Jimmy Pruitt III, PharmD, BCPS, BCCCP, BCEMP, a pharmacist and entrepreneur, earned his Doctor of Pharmacy degree from Presbyterian College and completed residencies at Florida Hospital Orlando and Grady Health System. He founded EMPowerRX Conference and Pharmacy & Acute Care University (PACU) to innovate healthcare education and inspire pharmacists to pursue entrepreneurship. In 2021, he received the Excellence in Diversity award and was named Alumni of the Year at Presbyterian College. Dr. Pruitt is also an Emergency Medicine Clinical Pharmacy Specialist at Atrium Health and hosts the "Pharm So Hard" podcast, aiming to educate and elevate the pharmacy profession. Mentioned on the Show Start by Jon Acuff Brooke Griffin on LinkedIn Kelley Carlstrom on LinkedIn Natalie Park on LinkedIn Jimmy Pruitt III on LinkedIn YFP Disclaimer Subscribe to the YFP Newsletter Tim Ulbrich on LinkedIn YFP on Instagram YFP Facebook Group  

 Monday, December 16th, 2024Today, more corporate media including ABC and Jeff Bezos are capitulating to Donald Trump's administration; a Coast Guard commander miscarried and nearly died after being denied care; Atrium Health has canceled medical debt for nearly 11,500 people after an NBC report; a Trump crypto venture partner has links to Iran and Hezbollah; an incoming West Virginia lawmaker has been charged with threatening to kill fellow lawmakers; Senate Democrats are demanding communications between Boris Epshteyn and potential Trump appointees; the missing American Travis Timmerman has been found in Syria; the Air Force has named the first female SERE specialist as chief master sergeant; Manchin and Sinema hate working class Americans; and Allison and Dana deliver your Good News.Thank You Helix SleepBig shoutout today to Helix Sleep. Helix is offering 20% off sitewide plus 2 FREE  Pillows with any mattress purchase when you go to HelixSleep.com/DailyBeans.Stories:North Carolina hospital company forgives debts of 11,500 people after NBC News report (NBC News)Missing American Travis Timmerman found in Syria is released to U.S. forces, officials say (Erik Ortiz and Mosheh Gains  | NBC News)ABC agrees to give $15 million to Donald Trump's presidential library to settle defamation lawsuit (Michael R. Sisak | AP News)Senate Democrats want communications between Boris Epshteyn and potential Trump appointees disclosed (Daniel Klaidman | CBS News)Trump crypto venture partners with platform linked to Middle East militants (Alexandra Ulmer and Simon Lewis | Reuters)Air Force names first female SERE specialist as chief master sergeant (airforcetimes)Have some good news; a confession; or a correction to share?Good News & Confessions - The Daily Beanshttps://www.dailybeanspod.com/confessional/From The Good NewsPictures of Belonging: Miki Hayakawa, Hisako Hibi, and Miné Okubo (americanart.si.edu)usda.govOffice of Weights and Measures (OWM) (use.gov)NASA.govThe Bureau of Engraving & PrintingNational Archives (archives.gov)USGS.gov Check out other MSW Media podcastshttps://mswmedia.com/shows/Subscribe for free to MuellerSheWrote on Substackhttps://muellershewrote.substack.comFollow AG and Dana on Social MediaDr. Allison Gill Substack|Muellershewrote, Twitter|@MuellerSheWrote, Threads|@muellershewrote, TikTok|@muellershewrote, IG|muellershewrote, BlueSky|@muellershewroteDana GoldbergTwitter|@DGComedy, IG|dgcomedy, facebook|dgcomedy, IG|dgcomedy, danagoldberg.com, BlueSky|@dgcomedyHave some good news; a confession; or a correction to share?Good News & Confessions - The Daily Beanshttps://www.dailybeanspod.com/confessional/ Listener Survey:http://survey.podtrac.com/start-survey.aspx?pubid=BffJOlI7qQcF&ver=shortFollow the Podcast on Apple:The Daily Beans on Apple PodcastsWant to support the show and get it ad-free and early?Supercasthttps://dailybeans.supercast.com/Patreon https://patreon.com/thedailybeansOr subscribe on Apple Podcasts with our affiliate linkThe Daily Beans on Apple Podcasts

Researchers uncover a critical Windows zero-day.  An alleged Ukrainian cyberattack targets one of Russia's largest banks. Russian group BlueAlpha exploits CloudFlare services. Microsoft flags Chinese hacking group Storm-0227 for targeting critical infrastructure and U.S. government agencies. SonicWall patches high-severity vulnerabilities in its secure access gateway. Atrium Health reports a data breach affecting over half a million individuals. Rockwell Automation discloses four critical vulnerabilities in its Arena software. U.S. authorities arrest an alleged member of the Scattered Spider gang. Our guest is Hugh Thompson, RSAC program committee chair, discussing the 2025 Innovation Sandbox Contest and its new investment component. C3PO gets caught in the crypto mines.  Remember to leave us a 5-star rating and review in your favorite podcast app. Miss an episode? Sign-up for our daily intelligence roundup, Daily Briefing, and you'll never miss a beat. And be sure to follow CyberWire Daily on LinkedIn. CyberWire Guest Joining Dave today is Hugh Thompson, RSAC program committee chair, discussing the 2025 Innovation Sandbox Contest and its new investment component. Read more details in the press release.  Selected Reading New Windows 7 To 11 Warning As Zero-Day With No Official Fix Confirmed (Forbes) Russian users report Gazprombank outages amid alleged Ukrainian cyberattack (The Record) BlueAlpha Russian hackers caught abusing CloudFlare services (SC Media) U.S. org suffered four month intrusion by Chinese hackers (Bleeping Computer) Microsoft: Another Chinese cyberspy crew targeting US critical orgs 'as of yesterday' (The Register) SonicWall Patches 6 Vulnerabilities in Secure Access Gateway (SecurityWeek) Mitel MiCollab zero-day and PoC exploit unveiled (Help Net Security) Atrium Health Data Breach Impacts 585,000 People (SecurityWeek) Rockwell Automation Vulnerabilities Let Attackers Execute Remote Code (Cyber Security News) US arrests Scattered Spider suspect linked to telecom hacks  (Bleeping Computer) Nebraska Man pleads guilty to $3.5 million cryptojacking scheme (Bleeping Computer) Share your feedback. We want to ensure that you are getting the most out of the podcast. Please take a few minutes to share your thoughts with us by completing our brief listener survey as we continually work to improve the show.  Want to hear your company in the show? You too can reach the most influential leaders and operators in the industry. Here's our media kit. Contact us at cyberwire@n2k.com to request more info. The CyberWire is a production of N2K Networks, your source for strategic workforce intelligence. © N2K Networks, Inc. Learn more about your ad choices. Visit megaphone.fm/adchoices

Megan Antonelli, Founder & CEO of HealthIMPACT and HealthIMPACT Chairperson Shahid Shah, Publisher & CEO, Medigy, join Eric to give Bright Spots in Healthcare listeners a sneak preview of the HealthIMPACT Forum 25, taking place on January 22-23, 2025, in New York City.    Megan and Shahid share what makes their event different from other healthcare conferences – purposeful content that creates conversations that lead to meaningful connections. They also discuss the theme, Powering the Patient-Led Revolution for Healthcare Anywhere and mention some key things to look forward to at the event, including Keynote Speaker Chelsea Clinton, who will lead a panel discussion on digital innovation.   In addition to Clinton, the conference's speakers include hospital leaders from top health systems, including Atrium Health, Mayo Clinic, Northwell Health, and Oschner Health.   Megan also discusses how HealthIMPACT partners with Road Recovery, which has been changing lives through music since 1998 by combining music industry mentorship with mental health support for young people battling addiction and adversity.    About HealthIMPACT HealthIMPACT isn't just another conference—it's a catalyst for change. For a decade, we've been the no-PowerPoint, no-BS platform where healthcare providers, payers, pharma, and patients converge to drive digital health implementation and adoption because you have to have both to make an IMPACT.   Join C-suite IT and clinical executives at the forefront of healthcare transformation as we explore how to deliver superior outcomes, enhance experiences, and achieve operational excellence in the new era of healthcare anywhere.   To register for the event, go to https://impactnyjan25.healthimpactlive.com/ Use the code BRIGHTSPOTSVIP to receive a 20% discount on the registration fee.   About Shahid Shahid N. Shah is an internationally recognized and influential healthcare IT thought leader who is known as “The Healthcare IT Guy” across the Internet. He is a consultant to various federal agencies on IT matters and winner of Federal Computer Week's coveted “Fed 100” award given to IT experts that have made a big impact in the government. Shahid has architected and built multiple clinical solutions over his almost 20-year career. He helped design and deploy the American Red Cross's electronic health record solution across thousands of sites; he's built two web-based EMRs now in use by hundreds of physicians; he's designed large groupware and collaboration sites in use by thousands; and, as an ex-CTO for a billion dollar division of CardinalHealth he helped design advanced clinical interfaces for medical devices and hospitals. Shahid also serves as a senior technology strategy advisor to NIH's SBIR/STTR program helping small businesses commercialize their healthcare applications. Shahid runs three successful blogs. At http://shahid.shah.org he writes about architecture issues, at http://www.healthcareguy.com he provides valuable insights on how to apply technology in health care, at http://www.federalarchitect.com he advises senior federal technologists, and at http://www.hitsphere.com he gives a glimpse of the health-care IT blogosphere as an aggregator.   About Megan A relentless creator and knowledge seeker who brings people together to solve big problems, Megan believes face-to-face meetings give everyone a shared focus, bringing forth new insights, a clearer sense of purpose, and solutions that impact long-term performance.   An experienced event executive with extensive knowledge of healthcare, technology, and corporate management strategy. Developed and managed hundreds of events for health system, physician, health plan, pharmaceutical, digital marketing, and technology executives. A creative and passionate leader interested in how technology is transforming healthcare delivery, the way people work, and global market dynamics.   We'd love to hear from you! Send your comments, suggestions and ideas to hello@brightspotsinhealthcare.com

Cone Beam CT has become a cornerstone of modern interventional practice. Are you utilizing it to its fullest potential? Dr. Michael Miller joins host Dr. Chris Beck to discuss Cone Beam CT, sharing advanced techniques and clinical pearls. Dr. Miller is an interventional radiologist and Associate Professor of Radiology at Atrium Health, Wake Forest Baptist Hospital, North Carolina. --- This podcast is supported by: GE Healthcare Allia Image Guided Systems https://www.gehealthcare.com/products/interventional-image-guided-systems/allia --- SYNPOSIS Dr. Miller explains the importance of fundamental training and how fundamentals can be scaled across various procedures to improve outcomes, including vascular malformations and endoleaks. Dr. Miller then speaks to best practices that he has learned firsthand through his years of using Cone Beam CT. The doctors also touch on tips for setting up the IR suite and collaborating with anesthesia. --- TIMESTAMPS 00:00 - Introduction 07:22 - Advanced Uses of Cone Beam CT 15:04 - Setup and Best Practices 22:34 - Vascular Malformations 23:32 - Understanding Sclerosant Distribution 26:53 - Trajectory Guidance in Complex Cases 32:45 - Contrast Bolus Timing and Spin Techniques 40:16 - Advice for New Angio Suites --- RESOURCES BackTable VI Podcast Episode #51 - Cone Beam CT Techniques with Dr. Austin Bourgeois: https://www.backtable.com/shows/vi/podcasts/51/cone-beam-ct-techniques Shujaat, S., Alfadley, A., Morgan, N., Jamleh, A., Riaz, M., Aboalela, A.A., Jacobs, R., 2024. Emergence of artificial intelligence for automating cone-beam computed tomography-derived maxillary sinus imaging tasks. A systematic review. Clin Implant Dent Relat Res 26, 899–912. https://doi.org/10.1111/cid.13352 Orth, R.C., Wallace, M.J., Kuo, M.D., Technology Assessment Committee of the Society of Interventional Radiology, 2009. C-arm cone-beam CT: general principles and technical considerations for use in interventional radiology. J Vasc Interv Radiol 20, S538-544. https://doi.org/10.1016/j.jvir.2009.04.026 Bapst, B., Lagadec, M., Breguet, R., Vilgrain, V., Ronot, M., 2016. Cone Beam Computed Tomography (CBCT) in the Field of Interventional Oncology of the Liver. Cardiovasc Intervent Radiol 39, 8–20. https://doi.org/10.1007/s00270-015-1180-6 Wallace, M.J., Kuo, M.D., Glaiberman, C., Binkert, C.A., Orth, R.C., Soulez, G., Technology Assessment Committee of the Society of Interventional Radiology, 2008. Three-dimensional C-arm cone-beam CT: applications in the interventional suite. J Vasc Interv Radiol 19, 799–813. https://doi.org/10.1016/j.jvir.2008.02.018 Bm, K., Sm, T., Mj, S., 2023. Cone-Beam CT With Enhanced Needle Guidance and Augmented Fluoroscopy Overlay: Applications in Interventional Radiology. AJR. American journal of roentgenology 221. https://doi.org/10.2214/AJR.22.28712 Kwok, Y.M., Irani, F.G., Tay, K.H., Yang, C.C., Padre, C.G., Tan, B.S., 2013. Effective dose estimates for cone beam computed tomography in interventional radiology. Eur Radiol 23, 3197–3204. https://doi.org/10.1007/s00330-013-2934-7

TopMedTalk at The American Society of Anesthesiologists (ASA)'s annual general meeting; Anesthesiology 2024. We're bringing you a series of podcasts from the conference. Make sure you check our podcast feed and are subscribed to TopMedTalk, as we are currently releasing episodes more often than usual to accommodate high demand. This piece provides much needed focus on the topic of pediatrics and hemodynamics. Is it true to say that children are completely different to adults? What information do we need and what should the considerations around this topic really be? Presented by Desiree Chappell and Mike Grocott with their guests Dwight Bailey, Chief, Division of Pediatric Critical Care Medicine at Atrium Health, Levine Children's Hospital and Jonathan Tan, Vice Chair of Analytics and Clinical Effectiveness, Department of Anesthesiology Critical Care Medicine, Assistant Professor of Clinical Anesthesiology and Spatial Sciences, Children's Hospital Los Angeles, Keck School of Medicine of the University of Southern California, Spatial Sciences Institute of the University of Southern California

In 2018, Dr. Dale Owen and nearly 90 physicians left Atrium Health to form Tryon Medical Partners, driven by a vision of patient-centered care without the bureaucracy of large health systems. This bold move, initiated amidst legal battles and skepticism, aimed to prioritize personalized care and coordination while reducing costs.Fast forward six years, Tryon Medical now serves nearly 200,000 patients in the Charlotte-Mecklenburg area, demonstrating the viability of independent practices despite immense challenges.In this episode of The Charlotte Ledger Podcast, Owen recounts the obstacles faced in establishing Tryon Medical "out of air" — from securing facilities and staff to building insurance partnerships. In a conversation with The Ledger's Tony Mecia, he discusses the lessons he has learned building a medical practice, the challenges of Covid, the complexities of the U.S. healthcare system and Tryon's growth plans following a partnership with a private-equity investment company.This podcast was produced by Lindsey Banks.For more information about The Charlotte Ledger, or to sign up for our newsletters, visit TheCharlotteLedger.com. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit charlotteledger.substack.com/subscribe

A Gaston County judge on Monday ordered that Joshua Hunsucker, a former paramedic from North Carolina, remain behind bars without bond after prosecutors described him as a danger to his children and in-laws. Hunsucker is accused of using tetrahydrozoline, a toxic chemical found in Visine eye drops, to murder his wife, 32-year-old Stacy Hunsucker, in 2018 and to poison their 10-year-old daughter in 2023. Prosecutors allege that Hunsucker attempted to implicate his wife's parents, John and Suzie Robinson, in both incidents. The Robinsons, who were present in court, had filed a motion in August requesting the revocation of Hunsucker's bond, citing concerns over alleged harassment and intimidation. They claim Hunsucker has been following them, harassing them, and attempting to remove them from their grandchildren's lives. Initially, the death of Stacy Hunsucker was attributed to natural causes due to reported heart issues. However, suspicions arose when it was revealed that her husband had requested no autopsy and a swift cremation. As an organ donor, tests on her organs and blood later detected the presence of tetrahydrozoline, leading to murder charges against Hunsucker in December 2019. He had been released on a $1.5 million bond at that time. In 2023, Hunsucker reported to the Mount Holly Police Department that John Robinson had attacked and kidnapped him. According to the police report, Hunsucker claimed he was pistol-whipped, zip-tied, and injected with an unknown substance. Authorities have found no evidence supporting these allegations. Prosecutors argue that Hunsucker fabricated the incident to frame the Robinsons and divert attention from his own actions. In addition to first-degree murder and insurance fraud charges related to his wife's death, Hunsucker now faces new charges connected to his daughter's alleged poisoning and the harassment of his in-laws. These include four counts of intimidation of a witness and four counts of obstruction of justice. While he was granted a $25,000 bond for these new charges, the judge noted that he would remain in custody due to the severity of the allegations and the revocation of his previous bond. "The poisoning of his daughter was once again done with an attempt to implicate Mr. and Mrs. Robinson in the death of his wife and remove the Robinsons from the lives of his daughters," the motion to revoke Hunsucker's bond stated. The Robinsons have expressed relief at the court's decision to keep Hunsucker detained, emphasizing their concerns for their safety and the well-being of their grandchildren. The case remains ongoing as prosecutors continue to build their case against Hunsucker.  AND! WHILE OUT ON BOND FOR HIS WIFE'S MURDER…. Hunsucker, charged with fatally poisoning his wife with eye drops in 2018, pleaded not guilty to felony arson on for allegedly setting a medical helicopter on fire. Joshua Hunsucker, accused of igniting a syringe pump mid-flight on November 26, 2019, forced the Atrium Health helicopter to make an emergency landing at a car dealership on Independence Boulevard in Charlotte. Hunsucker was charged with felony property damage to Atrium Health, posting bond shortly after his arrest. At the time, he was already out on bond awaiting trial for the alleged murder of his wife, Stacy Robinson Hunsucker. Just weeks after the helicopter incident, he was taken back into custody and formally charged with her murder. Want to listen to ALL of our podcasts AD-FREE? Subscribe through APPLE PODCASTS, and try it for three days free: https://tinyurl.com/ycw626tj Follow Our Other Cases: https://www.truecrimetodaypod.com The latest on The Downfall of Diddy, The Trial of Karen Read, The Murder Of Maddie Soto, Catching the Long Island Serial Killer, Awaiting Admission: BTK's Unconfessed Crimes, Delphi Murders: Inside the Crime, Chad & Lori Daybell, The Murder of Ana Walshe, Alex Murdaugh, Bryan Kohberger, Lucy Letby, Kouri Richins, Malevolent Mormon Mommys, The Menendez Brothers: Quest For Justice, The Murder of Stephen Smith, The Murder of Madeline Kingsbury, The Murder Of Sandra Birchmore, and much more! Listen at https://www.truecrimetodaypod.com

A Gaston County judge on Monday ordered that Joshua Hunsucker, a former paramedic from North Carolina, remain behind bars without bond after prosecutors described him as a danger to his children and in-laws. Hunsucker is accused of using tetrahydrozoline, a toxic chemical found in Visine eye drops, to murder his wife, 32-year-old Stacy Hunsucker, in 2018 and to poison their 10-year-old daughter in 2023. Prosecutors allege that Hunsucker attempted to implicate his wife's parents, John and Suzie Robinson, in both incidents. The Robinsons, who were present in court, had filed a motion in August requesting the revocation of Hunsucker's bond, citing concerns over alleged harassment and intimidation. They claim Hunsucker has been following them, harassing them, and attempting to remove them from their grandchildren's lives. Initially, the death of Stacy Hunsucker was attributed to natural causes due to reported heart issues. However, suspicions arose when it was revealed that her husband had requested no autopsy and a swift cremation. As an organ donor, tests on her organs and blood later detected the presence of tetrahydrozoline, leading to murder charges against Hunsucker in December 2019. He had been released on a $1.5 million bond at that time. In 2023, Hunsucker reported to the Mount Holly Police Department that John Robinson had attacked and kidnapped him. According to the police report, Hunsucker claimed he was pistol-whipped, zip-tied, and injected with an unknown substance. Authorities have found no evidence supporting these allegations. Prosecutors argue that Hunsucker fabricated the incident to frame the Robinsons and divert attention from his own actions. In addition to first-degree murder and insurance fraud charges related to his wife's death, Hunsucker now faces new charges connected to his daughter's alleged poisoning and the harassment of his in-laws. These include four counts of intimidation of a witness and four counts of obstruction of justice. While he was granted a $25,000 bond for these new charges, the judge noted that he would remain in custody due to the severity of the allegations and the revocation of his previous bond. "The poisoning of his daughter was once again done with an attempt to implicate Mr. and Mrs. Robinson in the death of his wife and remove the Robinsons from the lives of his daughters," the motion to revoke Hunsucker's bond stated. The Robinsons have expressed relief at the court's decision to keep Hunsucker detained, emphasizing their concerns for their safety and the well-being of their grandchildren. The case remains ongoing as prosecutors continue to build their case against Hunsucker.  AND! WHILE OUT ON BOND FOR HIS WIFE'S MURDER…. Hunsucker, charged with fatally poisoning his wife with eye drops in 2018, pleaded not guilty to felony arson on for allegedly setting a medical helicopter on fire. Joshua Hunsucker, accused of igniting a syringe pump mid-flight on November 26, 2019, forced the Atrium Health helicopter to make an emergency landing at a car dealership on Independence Boulevard in Charlotte. Hunsucker was charged with felony property damage to Atrium Health, posting bond shortly after his arrest. At the time, he was already out on bond awaiting trial for the alleged murder of his wife, Stacy Robinson Hunsucker. Just weeks after the helicopter incident, he was taken back into custody and formally charged with her murder. Want to listen to ALL of our podcasts AD-FREE? Subscribe through APPLE PODCASTS, and try it for three days free: https://tinyurl.com/ycw626tj Follow Our Other Cases: https://www.truecrimetodaypod.com The latest on The Downfall of Diddy, The Trial of Karen Read, The Murder Of Maddie Soto, Catching the Long Island Serial Killer, Awaiting Admission: BTK's Unconfessed Crimes, Delphi Murders: Inside the Crime, Chad & Lori Daybell, The Murder of Ana Walshe, Alex Murdaugh, Bryan Kohberger, Lucy Letby, Kouri Richins, Malevolent Mormon Mommys, The Menendez Brothers: Quest For Justice, The Murder of Stephen Smith, The Murder of Madeline Kingsbury, The Murder Of Sandra Birchmore, and much more! Listen at https://www.truecrimetodaypod.com

In this podcast episode we want to introduce you to our BCEN Friend, Crystal Bencken. Crystal Bencken is a Simulation Education Manager at Atrium Health Carolinas Simulation Center, where she leverages 16 years of experience in emergency nursing and trauma to enhance simulation-based education. Her expertise lies in developing projects that emphasize teamwork, communication, systems testing, and process improvement, ensuring that healthcare professionals are well-equipped to deliver optimal patient care. Crystal's commitment to fostering collaborative learning environments makes her a valuable asset in advancing simulation education initiatives. Come along as Janie Schumaker and Hollye Briggs talk with Crystal about her unexpected entry into nursing, her experiences during 9/11, and her realization that healthcare professionals must practice together to be effective. This episode is called, Simulation Education: Let the wild rumpus begin! Crystal can be reached on LinkedIn @CrystalBencken and on the Atrium Health website at https://atriumhealth.org/education/carolinas-simulation-center BCEN & Friends Podcast is presented by the Board of Certification for Emergency Nursing. We invite you to visit us online at https://bcen.org for additional information about emergency nursing certification, education, and much more.

In this episode, James Reynolds, Assistant Vice President at Atrium Health, discusses his work in outcomes, care transformation, and the trends shaping the future of healthcare. He shares insights into the impact of AI, remote patient monitoring, and the balance between fee-for-service and value-based care.

On this episode of DGTL Voices, Ed welcomes Dr. Dermot Phelan, a renowned sports cardiologist with Atrium Health and a key medical figure for professional athletes. Dr. Phelan shares insights from his roles of caring for elite athletes as the team cardiologist for the Carolina Panthers and Charlotte FC, as well as serving as the NFL's cardiology consultant. He also discusses the importance of servant leadership in healthcare and the lessons it offers for improving patient outcomes. Listen now to hear more about Dr. Phelan's perspective on sports cardiology, his work with the NFL, and his tips for improving your own heart health.

This episode's Community Champion Sponsor is Ossur. To learn more about their ‘Responsible for Tomorrow' Sustainability Campaign, and how you can get involved: CLICK HERE---Episode Overview: How can we build a sustainable, future-ready healthcare workforce to ensure exceptional patient care and advance health equity? Our next guest, Geoffrey Roche, is tackling this challenge as the inaugural North America Director of Workforce Development at Siemens Healthineers. With over 16 years of experience in hospital and higher education leadership, Geoffrey brings a unique perspective on bridging the gap between education and healthcare employment. Driven by a passion for diversity and innovation, Geoffrey shares Siemens Healthineers' pioneering vision to transform workforce development through strategic partnerships, apprenticeship programs, and cutting-edge technology. Join us to discover how Geoffrey and his team are attracting diverse talent, supporting current and future healthcare professionals, and revolutionizing career pathways to create a thriving, equitable healthcare ecosystem. Let's go!Episode Highlights:Geoffrey emphasizes the importance of developing workforce solutions by listening to the voices of patients and consumers, highlighting Siemens Healthineers' commitment to understanding and addressing real healthcare needs.Siemens Healthineers is tackling the critical shortage of imaging technologists, which is causing significant delays in patient care and financial losses for healthcare systems. Their approach includes attracting more diverse talent to the profession and creating supportive work environments.The company is partnering with academic institutions to create innovative educational programs that prepare students to be "future-ready" healthcare professionals, addressing both current workforce shortages and anticipated future needs.Geoffrey shares insights from a recent trip to the UK, where he studied their apprenticeship degree programs. He advocates for similar models in the US, allowing individuals to earn degrees while working and learning on the job.Siemens Healthineers is engaged in unique, long-term partnerships with major health systems like SSM Health and Atrium Health, focusing on community-based initiatives to improve economic mobility and healthcare access in underserved areas.About our Guest: Geoffrey M. Roche, MPA, is the son of a nurse, healthcare expert, diversity advocate, and education enthusiast, presently serving as the inaugural North America Director of Workforce Development at Siemens Healthineers, Executive Advisor, LEAD3R, Vice President, Axios Strategy, and National Healthcare Practice Executive Advisor at Core Education PBC. Roche speaks often on healthcare workforce topics at national conferences such as Becker's Annual Conference, HIMSS, HLTH, ASU+GSV, and ViVE. In 2022, Roche was nominated to the Forbes Business Council for his national level work.Roche has over 16 years of experience in hospital and higher education leadership in the United States. He has served on various boards and committees, including the United Way ofNorth Carolina, United Way of Lebanon County, United Way of Pennsylvania, and Patient Safety Committee for WellSpan Good Samaritan Hospital. Roche also presently serves on the JFFCorporate Innovation Council, representing the healthcare industry.Roche also serves as a Senior Advisor with Econsult Solutions, Partner with Product10x, DNPs of Color Advisory Committee, and Leavitt School of Health Advisory Council at Western Governors University, and strategic advisor to numerous...

The Healthcare Facilities Network sat down with Dennis Ford, Corporate Facilities Management for Atrium Health in Charlotte, NC. Dennis is running for the 2025 American Society of Healthcare Engineering (ASHE) Presidency. In this episode, we discuss Dennis' thoughts and strategies on:* The recently held ASHE Innovation Conference* His background and career path* Why he is running for the ASHE Presidency* His proposed platform as President* Challenges and opportunities in healthcare facilities managementOur thanks to Dennis for his time, and good luck to him in the election. Voting closes August 21.Check us out at https://cref.comOr send an email to pmartin@cref.com

This week on Rural Health Leadership Radio, we are wrapping up our series on NRHA's 2023 Fellows Program Policy Papers with Fellows Michelle Fortune and Abby Radcliffe. Michelle and Abby explored one of the hottest topics in healthcare, particularly impactful in rural – healthcare workforce shortages. The Fellows share short and long-term strategies in handling workforce shortages, as well as pragmatic and policy-based recommendations. “Everybody in every community can take some action in some way, and it doesn't have to be looking for that gigantic next step. The big is in the little, so do something.” – Michelle Fortune Michelle Fortune, MBA, BSN, FACHE is the President of Surgery and GI Service Line for Mercy Health in St Louis, MO. Prior to joining Mercy, Michelle led the Perioperative and Anesthesia Service Lines for Atrium Health and then served as a CEO for a Critical Access Hospital managed by the system which needed an operational turnaround. Michelle is a Certified Ambulatory PeriAnesthesia Nurse and a National Rural Health Fellow. She is currently participating in the NRHA Rural CEO Certification Program. Michelle has a passion for assuring the availability of high quality healthcare in rural communities. Her work in Rural Healthcare has brought her numerous honors, including being named the 2023 Rural Community Champion of the year by the North Carolina Rural Health Association for her work in advancing Cardiac Care in Rural North Carolina. Abby Radcliffe currently serves as the Senior Director of the Small and Rural Hospital Constituency Section at the Illinois Health and Hospital Association (IHA). She has worked with rural hospitals at IHA for over 17 years and has worked on several grant initiatives. In 2023, she served as a National Rural Health Association fellow and was also awarded the Rural Health Hero Award from the National Center for Rural Health Professions.  Abby graduated from Eastern Illinois University with a major in Speech Communication and a double minor in Business Administration and Public Relations. In 2005 she graduated from Miami University with an MA in Speech Communication. Abby has also worked in state government and development.

In this episode, Dr. Stacy Reynolds, Chief of Pediatric Emergency Medicine at Atrium Health shares her background, discusses current pediatric trends, and highlights initiatives aimed at improving pediatric emergency care across Atrium Health's extensive network.

This segment of “Cancer Registry World” features Dr. Roshan Prabhu, MD, the Director of the Proton Therapy Center at the Atrium Health - Levine Cancer Institute in Charlotte, NC. Dr. Prabhu discusses the application and importance of collecting registry information for patients treated with the relatively new radiation oncology technique of proton therapy. Please enjoy listening and learning!

At the 2024 European Hematology Association (EHA) Congress, CancerNetwork® spoke with a variety of experts in the hematologic oncology space about optimizing outcomes across different patient populations and subgroups based on updated research they presented at the meeting.  Manali Kamdar, MD, an associate professor of medicine-hematology and clinical director of Lymphoma Services at the University of Colorado Anschutz Medical Campus, in Colorado, spoke about data from the phase 1 TRANSCEND NHL 001 trial (NCT02631044) supporting the use of lisocabtagene maraleucel (liso-cel; Breyanzi) in earlier lines of therapy for patients with relapsed/refractory mantle cell lymphoma (MCL).1  Specifically, Kamdar highlighted how research should continue to focus on the potential utility of liso-cel in MCL subgroups such as those with TP53 mutations or blastoid morphology. Additionally, she stated that liso-cel may need to be further tested in earlier lines of therapy for patients with diffuse large B-cell lymphoma, including those with double-hit lymphoma. Michael R. Grunwald, MD, chief of the Leukemia Division and director of the Transplantation and Cellular Therapy Program at Atrium Health's Levine Cancer Institute, in North Carolina, discussed findings from the Prospective Observational Study of Patients With Polycythemia Vera (PV) in US Clinical Practices Trial (REVEAL) exploring risk factors for disease progression in patients with polycythemia vera (PV).2 According to Grunwald, a history of thromboembolic events, elevated white blood cell counts, and higher variant allele frequencies may contribute to a patient's likelihood of experiencing progression to myelofibrosis or acute myeloid leukemia (AML). Additionally, he highlighted ongoing research into the potential molecular factors that may prognosticate disease transformation in PV among a small cohort of patients enrolled on the REVEAL trial.3 Harry P. Erba, MD, PhD, a professor of medicine in the Division of Hematologic Malignancies and Cellular Therapy and the director of the Leukemia Program and Phase I Development in Hematologic Malignancies at Duke Cancer Institute, in North Carolina, discussed the clinical implications of data from the phase 3 QuANTUM-First study (NCT02668653).4  Specifically, findings demonstrated that continuation therapy with quizartinib (Vanflyta) elicited a more pronounced survival benefit vs placebo in patients with newly diagnosed FLT3-ITD–positive AML who did not undergo allogeneic hematopoietic stem cell transplant (allo-HSCT). However, Erba noted that survival outcomes were not significantly different in the quizartinib and placebo arms among patients who received allo-HSCT. References 1.        Palomba ML, Siddiqi T, Gordon LI, et al. Subgroup analyses in patients with R/R MCL treated with lisocabtagene maraleucel by prior lines of therapy and response to Bruton tyrosine kinase inhibitor from the TRANSCEND NHL 001 MCL cohort. Presented at the European Hematology Association (EHA) 2024 Congress; Madrid, Spain; June 13-16, 2024. P1126. 2.        Grunwald M, Zwicker J, Gerds A, et al. A real-world evaluation of risk factors for disease progression in patients with polycythemia vera (PV) enrolled in REVEAL. Presented at the 2024 European Hematology Association (EHA) Congress; June 13-16, 2024; Madrid, Spain. Abstract P1047. 3.        Crowgey E, Timmers C, Xue Z, et al. Analysis of molecular mechanisms and predictive biomarkers of disease transformation in polycythemia vera. Presented at the 2024 European Hematology Association (EHA) Congress; June 13-16, 2024; Madrid, Spain. Abstract S217. 4.        Sekeres MA, Erba H, Montesinos P, et al. QuANTUM-First: efficacy in newly diagnosed patients with FMS-like tyrosine kinase 3-internal tandem duplication–positive (FLT3-ITD+) acute myeloid leukemia (AML) who received continuation therapy. Presented at the 2024 European Hematology Association (EHA) Congress; June 13-16, 2024; Madrid, Spain. Abstract S142.

BUFFALO, NY- June 4, 2024 – A new research perspective was published in Oncotarget's Volume 15 on June 3, 2024, entitled, “Bruton's tyrosine kinase inhibitor-related cardiotoxicity: The quest for predictive biomarkers and improved risk stratification.” In this new perspective, researchers Jai N. Patel, Jai Singh, and Nilanjan Ghosh from Atrium Health discuss Ibrutinib — the first Bruton's tyrosine kinase (BTK) inhibitor approved for the treatment of patients with chronic lymphocytic leukemia (CLL). “While producing durable responses and prolonging survival, roughly 20–25% of patients experience dose limiting side effects, mostly consisting of cardiovascular toxicities like severe hypertension and atrial fibrillation.” While clinical predictors of BTK inhibitor-related cardiotoxicity have been proposed and may aid in risk stratification, there is no routine risk model used in clinical practice today to identify patients at highest risk. A recent study investigating genetic predictors of ibrutinib-related cardiotoxicity found that single nucleotide polymorphisms in KCNQ1 and GATA4 were significantly associated with cardiotoxic events. If replicated in larger studies, these biomarkers may improve risk stratification in combination with clinical factors. “A clinicogenomic risk model may aid in identifying patients at highest risk of developing BTK inhibitor-related cardiotoxicity in which further risk mitigation strategies may be explored.” DOI - https://doi.org/10.18632/oncotarget.28589 Correspondence to - Nilanjan Ghosh - nilanjan.ghosh@atriumhealth.org Sign up for free Altmetric alerts about this article - https://oncotarget.altmetric.com/details/email_updates?id=10.18632%2Foncotarget.28589 Subscribe for free publication alerts from Oncotarget - https://www.oncotarget.com/subscribe/ Keywords - cancer, BTK inhibitor, cardiotoxicity, biomarkers, risk, genetics About Oncotarget Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science. Oncotarget is indexed and archived by PubMed/Medline, PubMed Central, Scopus, EMBASE, META (Chan Zuckerberg Initiative) (2018-2022), and Dimensions (Digital Science). To learn more about Oncotarget, please visit https://www.oncotarget.com and connect with us: Facebook - https://www.facebook.com/Oncotarget/ X - https://twitter.com/oncotarget Instagram - https://www.instagram.com/oncotargetjrnl/ YouTube - https://www.youtube.com/@OncotargetJournal LinkedIn - https://www.linkedin.com/company/oncotarget Pinterest - https://www.pinterest.com/oncotarget/ Reddit - https://www.reddit.com/user/Oncotarget/ Spotify - https://open.spotify.com/show/0gRwT6BqYWJzxzmjPJwtVh Media Contact MEDIA@IMPACTJOURNALS.COM 18009220957

Janice Walker joined Advocate Health in 2024 as Senior Vice President and Chief Nursing Officer – Southeast Region of Advocate Health. She is responsible for providing strategic leadership for all nursing and other designated patient care functions and services for Atrium Health, which comprises the entirety of Advocate Health's Southeast Region. Janice leads more than 18,000 nurses at Atrium Health's 40 hospitals and hundreds of care locations throughout North Carolina, South Carolina, Georgia and Alabama.She has 25 years of experience in health care with progressive leadership roles as a Chief Nursing Officer and a Chief Operating Officer in for-profit and not-for-profit health care entities. Her previous experience includes more than 13 years at Baylor Scott & White Health (BSW), and that is where I first met Janice.  At BS&W she oversaw nursing, pharmacy, lab, radiology and Joint Commission/CMS accreditation/certification.Chasing What Matters Instagram

Recorded at the first annual “HemOnc Pulse” Live meeting, this episode features a panel discussion on unanswered questions in myeloproliferative neoplasms (MPN) with Naveen Pemmaraju, MD, of the University of Texas MD Anderson Cancer Center; Ruben Mesa, MD, of the Atrium Health cancer service line; Sanam Loghavi, MD, of the MD Anderson Cancer Center; and Olatoyosi Odenike, MD, of the University of Chicago Medicine.

Welcome back to BOOST! In this episode, True Morse, Karen Hart Huey, and Bill Payne share *entertaining* stories, strategies, and the secrets behind their impactful careers working together as an ego-aside team to make an impact, a phenomenon knows as "True Hart Payne," or "THP" for short. True Morse retired in 2022 after 43 years in healthcare facility planning, design, and construction. True's career spanned nine states, focusing on developing and nurturing teams. Karen Hart Huey is currently the AVP of Planning, Real Estate & Space Management at WFU and formerly VP of Facilities for Wake Forest Baptist Health. Karen pivoted from healthcare to higher education after leading numerous critical functions and responding to COVID-19 as part of the Incident Command Center. Bill Payne serves as the AVP of Planning, Design & Construction at Atrium Health in the Wake Forest market. With three decades of experience, Bill combines technical expertise with strategic vision to ensure efficient and safe facility operations.

Dr. Aaron Brandt sat down with James R. Ficke, MD, FACS, FAOA, Department Chair of Johns Hopkins, and Joseph R. Hsu, MD, FAOA, Trauma and Deformity Surgeon at Carolinas Medical Center in Atrium Health in Charlotte, to discuss meaningful mentorship during early career. This conversation focuses on what they believe led them on a path to success, and how they have gotten the most out of both experiences – being a mentor and as a mentee. Their discussion communicates the importance of honesty and vulnerability when making relationships, and how this gives both parties the ability to trust one another. Throughout their chat, Drs. Brandt, Ficke, and Hsu, share numerous stories on how their relationships began, and the ways they were able to capitalize on being their genuine selves.  

Dr. Shaalan Beg and Dr.Mohamed Salem discuss key abstracts that will be presented at the 2024 ASCO Annual Meeting, including hypoxia-response CAR T- cell therapy for solid tumors, GPC3-specific CAR T- cell therapy in hepatocellular carcinoma, and the promising efficacy of targeted therapies in GI cancers.  TRANSCRIPT Dr. Shaalan Beg: Hello and welcome to the ASCO Daily News Podcast. I am Dr. Shaalan Beg, your guest host of the podcast today. I'm an adjunct associate professor at UT Southwestern's Simmons Comprehensive Cancer Center. In today's episode, we'll be discussing some key abstracts in GI cancers that will be presented at the 2024 ASCO Annual Meeting. I'm delighted to welcome Dr. Mohammed Salem, a GI medical oncologist at the Levine Cancer Institute at Atrium Health, for this discussion. Our full disclosures are available in the transcript of this episode. Mohammed, it's great to have you back on the podcast. Dr. Mohamed Salem: Thank you, Dr. Beg. It's always a pleasure to be here. Thanks for having me.  Dr. Shaalan Beg: So we're seeing more and more exciting data emerge on the role of ctDNA in GI cancers. And that's a topic that we've covered fairly extensively on the podcast. This year, in Abstract 3513, investigators used a novel, highly sensitive HPV ctDNA assay to evaluate the clinical outcomes of HPV ctDNA status in people with localized anal cancer treated with chemoradiation. And we know that prior HPV infection is associated with 90% of anal cancers. Can you give us a summary of the study and why it's so important to the clinical care we're giving our patients today?  Dr. Mohamed Salem: Sure. So, as you already alluded to, in the current era of precision oncology or precision medicine in general, there is an effort to try to maximize treatment efficacy and minimize the side effects. We're trying to understand how to do that by developing more biomarkers. I think this was a very interesting study that was led by Dr. Morris of MD Anderson. As you mentioned, he tried to determine the correlation between that circulating tumor DNA at different timelines and also associated that with the relapse. Obviously, as we all know, HPV infection is linked to about over 90% of anal cancers, and anal cancer is increasingly common in the U.S.  The study design includes patients from stage 1, 2, and 3 anal cancer treated with curative intent concurrent chemo radiation and the plot sample to collect circulating DNA was taken at five weeks of treatment and then at various intervals, including 3months, 6  months, 9 months and 12 months, to detect the HPV circulating DNA. And the analysis was done to correlate detection of circulating DNA with a relapse.  So what they observed is after collecting the samples at the end of the treatment, which is 5 weeks, followed by 3 months, 6 months, 9 months, and 12 months following treatment using the correlation between the detection of circulating tumor DNA as well as the recurrence rate, they were able to identify that about 22% was seen at 5 weeks, 13% was seen at three months, then 10% was seen at 6 months, and 0% actually was seen at 12 months. In the final analysis, they concluded that detection of circulating DNA at 3 months was significantly associated with a relapse rate of those patients. And also, they looked at the baseline stage, T stage, end stage, age and other perhaps prognostic factors. But the clinical implication of that trial is this finding supports the potential of integrating now the circulating DNA analysis and routine post-treatment surveillance, which hopefully will help us identify those patients with high risk of relapse and whether they can be treated with adjuvant therapy  in context-free drug trial or even like more close surveillance. Obviously, this is a very novel study, so it needs validation. Also, we need to understand more about the platform used because with the immersion technology and how fast this field is moving, I think it's important to look at this platform or other platforms. I think as a concept it's very interesting and hopefully will help us to identify patients with higher risk. So, I'm looking forward to hearing the full presentation. Dr. Shaalan Beg: Moving on to colorectal cancer, Abstract 3514 is a trial of hypoxia-responsive CEA CAR T-cell therapy for people with heavily pretreated solid tumors where this was administered intraperitoneally or intravenously. And you know, as a solid tumor oncologist or GI oncologist, we've been watching the hematologic space evolve so dramatically in the last five years with cellular therapies that it's exciting to see these CAR T-cell approaches being applied in solid tumors with some results. So can you talk about this study and whether you think it will influence clinical practice?  Dr. Mohamed Salem: Of course, I'm actually very excited to see this study because as you mentioned, CAR T-cell therapy has been utilized in hematological malignancies for the last several years and in fact it's becoming a center of care. As you know, it's very effective in certain tumors. Unfortunately, we did not see a similar result in solid tumors thus far. I know we are trying to make progress, but we are definitely not seeing the same efficacy in solid tumors. And also, of course, in CRC and many other tumors, we need more target options, so I was very excited to see this abstract. And I want to give a little bit of background why this abstract is important. Many solid tumors have a low oxygen level environment, hypoxia obviously, which can impact the effectiveness of CAR T therapy. So hypoxia can suppress the immune response, leading to poor performance of the immune cells like the T cell within the tumor. The investigators, to overcome that challenge, meaning hypoxia impacting the efficacy of the T cell, they were actually able to engineer a CAR T cell to be hypoxia responsive. And what does that mean? That the cells are designed to become more active in low oxygen conditions, which is more difficult in many of the solid tumors. The reason that's very interesting is because, one, it reduces exhaustion of the T cell, meaning like when you have the T cell active all the time, they get exhausted. So when you have the T cell in the resting state, until they reach the tumor environment and they get activated by the hypoxia status, now you reduce the expulsion of the T cell. But also that one overcomes the resistance. So once activated in the tumor hypoxic environment, this CAR T cell shows increased efficacy in targeting and killing the cancer cell.  Based on that concept, the investigators conducted a phase 1 dose escalation study in solid tumors. So this was a phase 1 open label group escalation study involving patients with tumor suppressed CEA and also had relapsed refractory second line treatment. The trial actually included 2 routes of administration, which I think was very interesting – IV versus intraperitoneal, IP, way of administration. And they enrolled about 40 patients between June of 2022 and January 2023. And 35 patients had colorectal cancer, 3 patients had gastric cancer, and 2 patients had non-small cell lung cancer. Overall, there was no surprising safety data. In terms of side effects, it was largely macrocystis, colitis. Unfortunately, they had 1 treatment that did not finish. But the interesting feature was the efficacy of that concept was demonstrated and in fact they were able to see more disease response and control at this rate with IP infusion, which I think is a very novel approach. I would look forward to trying and looking into this kind of delivery, especially in CRC and other tumors. Dr. Shaalan Beg: Because we've known that historically managing disease intraperitoneally has been challenging with cytotoxic chemotherapies and even surgical approaches that have been deployed can be fairly morbid as well. So looking at novel delivery mechanisms can help us understand, maybe be able to manage side effects of treatments in different ways and open doors for treatment in diseases that otherwise we couldn't manage. So definitely a very novel and exciting approach on this study.  Dr. Mohamed Salem: I agree. I think the idea of administering an IP route is a very interesting idea.   Well, Shaalan, there is another study in CRC, Abstract 3515. This is the first human study of ABBV-400, cMET–targeting antibody-drug conjugate in advanced solid tumors. Can you tell us about this promising data? Dr. Shaalan Beg: Yeah, so we've known that cMET is a very relevant biomarker across many cancers, particularly colorectal cancer, and it is overexpressed in a fairly large proportion of multiple diseases. But there hasn't been an effective regimen that has been found to be tolerable to target this specific biomarker. In this study, the investigators are evaluating an antibody drug conjugate, which takes the cMET targeting antibody telisotuzumab and conjugates it to a novel topoisomerase one inhibitor payload. And there's a phase one study that enrolled people across multiple different tumor types. This was presented at ASCO 2023. And this year, the investigators are coming in and giving the results of a colorectal cancer cohort within that study. Patients were enrolled in the dose escalation phase, and in the dose expansion phase, there were 122 colorectal cancer cases; so a fairly healthy size colorectal cancer population. And the median number of prior lines of therapy was 4, which is fairly consistent with what we would expect in our clinical population for people with colorectal cancer. So what they found in terms of efficacy is that the response rates, the confirmed overall response rates, were between 15 and 20%, depending on what dose of the medication the patients had received. They enrolled people regardless of cMET expression and then evaluated the response based on a higher or lower cMET expression. And those with higher cMET expression had an overall response rate of >30%, while those with lower cMET expression had a response rate of 10 to 15%. So they still had a response rate, which for fifth-line colorectal cancer is something to be aware of and it could be a marker of more significant clinical activity than other treatments that are out there.  And with the antibody drug conjugates, it's also important for us to keep an eye on the side effect profiles because a lot of these agents can have distinct side effect profiles that otherwise we wouldn't be familiar with. And in this study, 64% of participants had a grade 3 or above treatment emergent adverse events, and 41% had serious adverse events. So definitely something to think about. And most of these were hematologic toxicities, 30% had grade 3 or worse anemia. Neutropenia was seen, in grade three and above, was seen in 25%, leukopenia or grade three and above was seen in 12%, and thrombocytopenia again around 12%. And the non-hematologic toxicities were nausea, fatigue, vomiting and diarrhea. There was some interstitial lung disease, pneumonitis, which was seen in 7% of the total population, of which 2% had grade three or above. So definitely something to think about. From my perspective, I really am excited about this presentation because we're seeing evidence of clinical activity focused on cMET for refractory colorectal cancer compared to other agents that are out in the market. If this pans out in future studies, it could definitely change the way we deliver our treatments. Dr. Mohamed Salem: I totally agree that we actually need more therapy for those patients. And I'm not surprised that the myelosuppression, as you mentioned, was in fifth-line treatment. So this patient had large exposure to cytotoxic agents before.   So, looking at CAR T once more, there is a very interesting Abstract 4019, which is a study of C-CAR031, a GPC3-specific TGFβRIIDN armored autologous CAR T, in patients with advanced hepatocellular carcinoma (HCC). What are your key takeaways from this study, Shaalan? Dr. Shaalan Beg: This is a first-in-human study. It enrolled people with advanced HCC who failed on one or more lines of prior therapy and they were given one single infusion of C-CAR031 after standard lymphodepletion and they enrolled 24 patients across 4 dose levels. If we look at the overall response rate, 50% of the 22 people who were eligible for response assessments had a partial response. This response rate varies based on the dose level itself and the investigators claim a 90% disease control rate. So definitely when we think about standard treatments for hepatocellular cancer after first line therapy, this is something which will catch a lot of people's attention. Again, with CAR T-cell therapy, we need to be aware of the risk of potential toxicities. There were no dose limiting toxicities and CRS or cytokine release syndrome was observed in 91% of patients, while a very small proportion, about less than 5%, had grade three CRS. Most of the side effects here were, again, lymphocytopenia, neutropenia, thrombocytopenia, and some transaminitis in 16% of patients. They did see tumor reduction in 90%, not only in the intrahepatic disease, but also in the extrahepatic disease. And again, these are people who had BCLC stage C disease. So this included people with hepatic and extrahepatic metastases. And in terms of prior lines of therapy, 96% of patients had either received immune checkpoint inhibitors and TKIs.  If we think about how some other immune therapy regimens are being developed in the GI cancer space, there is some indication that liver lesions may respond differently compared to extra hepatic disease. So in this case, they saw responses in both scenarios, which makes it very exciting, because even though we've seen many approvals of TKIs and immunotherapy, anti-androgenic therapy in hepatocellular cancer, the treatment of these patients is still extremely difficult because of their underlying hepatic dysfunction. And it'll be very interesting to see how this treatment unfolds.  Dr. Mohamed Salem: You summarized it very well, Shaalan. I echo your thoughts. What is also interesting about that study, it's actually targeted at the GPC strain, which is prevalent in HCC but not normal tissue, which goes back to your comment about the toxicity, and hopefully we can also manage treatment in the context of underlying liver disease.  Dr. Shaalan Beg: I guess it's fair to say that we're both very excited to see what's ahead in GI cancers at the Annual Meeting.   Mohamed, thanks as always for sharing your great insights with us on the ASCO Daily News Podcast.  Dr. Mohamed Salem: Thank you all for having me, and I'm looking forward to meeting you and all our colleagues in Chicago in a couple of weeks. Dr. Shaalan Beg: And thank you to our listeners for your time today. You'll find links to the abstracts discussed today in the transcripts of this episode. I'll be back to cover late breaking abstracts and other key advances in GI oncology after the annual meeting, so please join me for more key insights from ASCO24 and on the ASCO Daily News Podcast. Finally, if you value the insights that you hear on the podcast, please take a moment to rate, review, and subscribe wherever you get your podcasts.   Disclaimer: The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.   Find out more about today's speakers:  Dr. Shaalan Beg  @ShaalanBeg  Dr. Mohamed Salem  @SalemGIOncDoc    Follow ASCO on social media:  @ASCO on Twitter ASCO on Facebook ASCO on LinkedIn   Disclosures: Dr. Shaalan Beg:  Consulting or Advisory Role: Ispen, Cancer Commons, Foundation Medicine, Genmab/Seagen  Speakers' Bureau: Sirtex  Research Funding (An Immediate Family Member): ImmuneSensor Therapeutics  Research Funding (Institution): Bristol-Myers Squibb, Tolero Pharmaceuticals, Delfi Diagnostics, Merck, Merck Serono, AstraZeneca/MedImmune    Dr. Mohamed Salem: Consulting or Advisory Role: Taiho Pharmaceutical, Exelixis, Bristol-Myers Squibb, Exelixis, QED Therapeutics, Novartis, Pfizer, Daiichi Sankyo/Astra Zeneca  Speakers' Bureau: Genentech/Roche, Taiho Pharmaceutical, Daiichi Sankyo/Astra Zeneca, BMS, Merck 

Developing Leaders Through Schools of Experience, Pt. 1 The theory of Schools of Experience highlights that one is not born a leader, but rather a leader's abilities are developed through their work and life experiences. Join Dr. Jean Wright and host Ann Somers Hogg as they discuss lessons from Jean's Schools of Experience, including her current role as CEO of the COPD Foundation and her prior role as Chief Innovation Officer at Atrium Health (now Advocate Health), and how these “courses” have taught her the need for speed, the importance of analogous learning, and the reason to go broad, not just deep. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

Tune in as Erik Summers, Chief Medical Officer at Atrium Health Wake Forest Baptist, shares insights into healthcare trends and strategic growth. Gain valuable perspectives on implementing impactful changes and navigating future developments in the healthcare landscape.

Tune in as Erik Summers, Chief Medical Officer at Atrium Health Wake Forest Baptist, shares insights into healthcare trends and strategic growth. Gain valuable perspectives on implementing impactful changes and navigating future developments in the healthcare landscape.

On this episode of Pophealth Week, we feature Kehlin Swain,CEO and Co-founder of Xplosion Technology, a software engineer who has created a suite of digital health products in the rehabilitation, diabetes, and obesity management sector, and Dr. Zeev Neuwirth a healthcare executive whose most recent role was Chief Clinical Executive for Care Transformation at Atrium Health. Dr. Neuwirth has over 15 years of clinical practice experience and 15 years in clinical operations, population health and strategic services. In 2017, he launched the award-winning 'Creating a New Healthcare' podcast. In 2019 he published his first book, Reframing Healthcare - a Roadmap for Creating Disruptive Change. In September 2023, he published a second book, Beyond the Walls - the Megatrends, Movements & Market Disruptions Transforming American Healthcare. We discuss the state of tranformation of the U.S. ecosystem and the upside impact of digital health on chronic disease.

Join us for an insightful audio discussion with Regina Schomberg, System Director Pharmacy II at Atrium Health, as she shares her background and expertise. Regina delves into the latest healthcare trends, the evolution of Atrium Health's pharmacy program, and identifies key opportunities for growth and value addition within the system.

Join us for an insightful audio discussion with Regina Schomberg, System Director Pharmacy II at Atrium Health, as she shares her background and expertise. Regina delves into the latest healthcare trends, the evolution of Atrium Health's pharmacy program, and identifies key opportunities for growth and value addition within the system.

In this episode, Carmen and Stephanie interview the new CNE for Atrium Health. Dr. Janice Walker shares about her extensive nursing career and accomplishments.

Infertility and Sex In this conversation, Dr. Sophia Goodridge and Dr. Gillian Stearns discuss infertility, stress, and sex. They share their personal experiences and journeys with infertility, highlighting the emotional toll it can take on individuals and relationships. The conversation also addresses the lack of education and support surrounding infertility and the challenges faced by women in balancing their careers and fertility. The importance of open communication, humor, and seeking support is emphasized throughout the discussion. Takeaways We define infertility Infertility is a common and often taboo topic that affects many individuals and couples. The emotional toll of infertility can strain relationships and impact sexual intimacy. Education and support are crucial in navigating the challenges of infertility. The role of IVF drugs on your sex life. We discuss the world they wish to see in regards to education and normalizing infertility. Open communication, humor, and seeking support can help maintain strong partnerships during infertility struggles. Dr. Sophia Delpe Goodridge is board certified in Urology and Female Pelvic Medicine and Reconstructive Surgery. Her current  practice is in Roswell, GA and her interests include pelvic floor dysfunction, voiding dysfunction, urinary incontinence, overactive bladder and pelvic organ prolapse.    Dr. Gillian Sterns is a Urologist at Atrium Health, Director of Medical Student Education at Wake Forest, North Carolina FirmTech sponsors this podcast today. Go to ⁠myfirmtech.com⁠ and enter code NOTBROKEN for 15% off today. Our other amazing podcast sponsors To learn more about Solv Wellness and their products for female pelvic health, visit ⁠solvwellness.com⁠ for 30% off your first purchase of any product. Discount automatically applied at checkout. Women of all ages deserve to feel fantastic. And we can—because there is relief to be found. Go to ⁠myalloy.com⁠ to start your virtual appointment today. Use code NOTBROKEN20 it's good for $20 off any purchase, one time use, and expires July 31, 2024 Check out details for my retreat: https://ascendretreats.com/2024-kellycasperson-sedona/ Listen to my Tedx Talk: Why we need adult sex ed   Take my NEW Adult Sex Ed Master Class: https://www.kellycaspersonmd.com/adult-sex-ed   Join my membership to get these episodes ASAP, a private facebook group to discuss and my private accountability group for your health, hormones and life support! www.kellycaspersonmd.com/membership --- Send in a voice message: https://podcasters.spotify.com/pod/show/kj-casperson/message

This edition of Cancer Registry World features guest Michael Serwint, MD, ODS-C at Atrium Health Wake Forest Baptist in Winston Salem, NC. Dr. Serwint brings a unique and fascinating perspective to his cancer registry experience as a former practicing medical oncologist who eventually became a Certified Oncology Data Specialist. Please enjoy listening and learning!

Join Laura Dyrda from Becker's Healthcare as she interviews Robert Rose, Market Chief Nurse Executive at Atrium Health, exploring key healthcare issues and leadership strategies. Gain insights into Rose's background, perspectives on healthcare trends in 2024, excitement, concerns, and essential qualities for effective leadership in the evolving healthcare landscape.

Michael Horton is joined by Ann Tarwater to discuss the place of art in the Christian life, if art is just for the elites, and how churches can emphasize truth, but neglect goodness and beauty. Ann started her career as a model for famous American fashion designers Oscar de la Renta, Mary McFadden, Alpert Nipon, and many others. She also graduated with a Masters of Divinity from Reformed Theological Seminary in Charlotte, North Carolina. Building upon her background in modeling and fashion as well as theology, Ann launched The Appropriate Method, a business teaching etiquette and protocol to children and adults. Ann currently serves on the Advisory Board for the Arts at Queens University, the Board of Craft and Design for the Mint Museum, and the Chaplains Advisory Board for Atrium Health. CHECK OUT THIS MONTH'S OFFERS: Sign up to receive an original art print for this series at whitehorseinn.org/offers Subscribe to Modern Reformation magazine, and don't miss this month's issue, “The Arts.” Become a Partner to support the work of White Horse Inn as we apply the riches of the Reformation to the modern church. For more information, visit us at whitehorseinn.org or email us at info@whitehorseinn.org Featuring: Michael Horton and Ann Tarwater

Black and African American people diagnosed with Parkinson's disease (PD) face disparities in healthcare access and outcomes, potentially leading to decreased access to care, resources, and research opportunities. It is crucial to recognize their unique needs and experiences so that scientists can better understand how PD impacts diverse communities. The Parkinson's Foundation aims to identify these healthcare disparities to better serve and support the community. In this first episode of our Black History Month special, Kimberly Gamble, Program Coordinator at Atrium Health, and Lance Wilson, Licensed Social Worker and Center Coordinator at Jefferson Health's Comprehensive Parkinson's Disease and Movement Disorders Center, share real-life examples of outreach strategies that they have used when engaging with the Black and African American community to dispel common misconceptions about research studies, and emphasize the importance of representing and showing up for your community.

Join Laura Dyrda from Becker's Healthcare as she interviews Anthony Martin, Clinical Assistant Professor of Family Medicine at Wake Forest School of Medicine, Atrium Health, discussing trends in healthcare and sports medicine. Gain insights into Dr. Martin's background, his excitement and concerns for the upcoming year, and his experience caring for elite athletes, along with valuable advice for early-career physicians interested in sports medicine.

Jimmy Pruitt, PharmD, Founder & CEO of Pharmacy & Acute Care University, shares insights on his entrepreneurial journey and the EMPower Rx Conference. Summary In this week's episode, join our conversation with Dr. Jimmy Pruitt, a Clinical Pharmacy Specialist in Emergency Medicine at Atrium Health. Dr. Pruitt wears multiple hats as the Founder & CEO of Pharmacy & Acute Care University and the brains behind the EMPowerRx Conference. Our conversation delves into his fascinating entrepreneurial journey, exploring the roots of why and how he embarked on this path. Throughout the episode, we gain valuable perspectives on the intricacies of balancing professional commitments and entrepreneurial endeavors. Dr. Pruitt shares his experiences, lessons learned, and the strategies he employed to overcome obstacles on his journey. Dr. Pruitt also shares his vision for the EMRower Rx Conference - a  unique conference and continuing education experience for professionals in emergency medicine pharmacotherapy.  Tune in to this insightful conversation with Dr. Jimmy Pruitt to glean wisdom from his unique blend of clinical expertise and entrepreneurial spirit. Whether you're navigating the realms of healthcare, entrepreneurship, or both, this episode offers valuable insights and inspiration for the road ahead. About Today's Guest Dr. Jimmy Pruitt is originally from Orlando, FL, and is a combination of nerd and gym junky having a background as a division 1 cornerback then turned Doctor of Pharmacy from Presbyterian College School of Pharmacy in 2017. He completed a PGY-1 Pharmacy Residency at Florida Hospital Orlando, and then went on to Grady Health System in Atlanta GA for his PGY2 Emergency Medicine Residency. Dr. Pruitt is currently an Emergency Medicine Clinical Pharmacy Specialist at the Medical University of South Carolina in Charleston, SC. Dr. Pruitt was honored with the Excellence in Diversity from MUSC College of Pharmacy, Presbyterian College School of Pharmacy (PCSP) Alumni of the Year, and keynote speaker for the 2021 PCPS graduation. Dr. Pruitt's professional interests include cardiac arrest, shock syndromes, trauma, and hosting the #1 Emergency Medicine Pharmacy Podcast “Pharm So Hard” and operation his new pharmacy academy called Pharmacy & Acute Care University. Mentioned on the Show EMPowerRx Conference 2024 (use code YFP2024 for 15% off registration) YFP Episode 284 Start by Jon Acuff Procrastinate on Purpose by Rory Vaden Your Financial Pharmacist Your Financial Pharmacist on Facebook  Your Financial Pharmacist on Instagram Tim Ulbrich on LinkedIn Jimmy Pruitt on LinkedIn YFP Disclaimer YFP Newsletter Pharm So Hard Podcast

The CE experience for this Podcast is powered by CMEfy - click here to reflect and earn credits: https://earnc.me/w9443h When Dr. Brown was having chest pains, she did what you are supposed to do - Seek help. What she discovered while attempting to get that help changed her career path forever.  Perhaps talking with a coach might help to answer and review your own professional biases.  Visit us at https://www.mymdcoaches.com Dr. Jonisha Brown is a Family Medicine assistant professor and hospitalist at Atrium Health in Charlotte, NC. She attended Wake Forest University Bowman Gray School of Medicine for medical school and completed her residency at Atrium Health where she specialized in underserved medicine and served as Chief Resident.  Most recently, Dr. Brown completed her Master of Public Health Degree from Harvard School of Public Health with a concentration in Health Policy.  Her area of expertise includes addressing racism and implicit bias in medicine, ending Black maternal health disparities, and supporting diversity and inclusion in medicine. She is also the founder of BirthRight Inc, a nonprofit in Charlotte North Carolina that addresses the root causes of the Black maternal health crisis through community education, empowerment, and advocacy efforts. -+=-+=-+=-+=-+=-+=-+=-+=-+=-+=-+=-+=-+=-+=-+=-+=-+=-+=-+=-+=-+=-+= This Episode is brought to you today by Eagle Financial Group. Eagle Financial Group is here to help you understand your numbers to make wise decisions. From fractional CFO services to accounting, bookkeeping, and payroll, Eagle financial group is your partner to ensure that your practice keeps on serving your patients, and gives you more time to spend with your family and friends. It's time that you overcome your obstacles, and get control of your financial life today. Give Eagle Financial Group a call at 719-755-0043, drop us an email at clientservices@eaglefsg.com, or visit us on line at eaglefsg.com -+=-+=-+=-+=-+=-+=-+=-+=-+=-+=-+=-+=-+=-+=-+=-+=-+=-+=-+=-+=-+=-+= Are you a doctor struggling to provide the best care for your patients while dealing with financial and caregiving matters out of the scope of your practice? Do you find yourself scrambling to keep up with the latest resources and wish there was an easier way? Finally, our Virtual Health and Financial Conference for Caregivers is here! This conference helps you and your patients enlist the best strategies around health care resources and the best financial steps for your patients to take while navigating care. You don't have to go home feeling frustrated and helpless because you couldn't connect your patients with the best services. In just 90 minutes, our VIP Live Roundtable will answer your questions and be the lifeline that helps your patients put together an effective caregiving plan. Find out more at Jeanniedougherty.com and click on Conference for Caregivers VIP. -=+=-=+=-=+=-=+=-=+=-=+=-=+=-=+=-=+=-=+=-=+=-=+=-=+=-=+=-=+=-=+=-   Join the Conversation! We want to hear from you! Do you have additional thoughts about today's topic? Do you have your own Prescription for Success? Record a message on Speakpipe     Unlock Bonus content and get the shows early on our Patreon Follow us or Subscribe: Apple Podcasts | Google Podcasts | Stitcher | Amazon  | Spotify --- Show notes at https://rxforsuccesspodcast.com/LCM33 Report-out with comments or feedback at https://rxforsuccesspodcast.com/report Music by Ryan Jones. Find Ryan on Instagram at _ryjones_, Contact Ryan at ryjonesofficial@gmail.com Production assistance by Clawson Solutions Group, find them on the web at csolgroup.com      

Audible Bleeding editor Wen (@WenKawaji) is joined by 5th year general surgery resident Richa Kalsi (@KalsiMD) from University of Maryland Medical Center, 3rd year general surgery resident Sasank Kalipatnapu (@ksasank) from UMass Chan Medical School, JVS editor Dr. Forbes (@TL_Forbes), and JVS-CIT editor Dr. Smeds (@matsmeds) to discuss two great articles in the JVS family of journals regarding endosuture aneurysm repair mid-term follow-up and endovascular repair of thoracic aortic aneurysm with aberrant subclavian artery. This episode hosts Dr. Frank Arko (@farkomd), Dr. Sukgu Han (@SukguH), and Dr. Fernando Fleischman, authors of the following papers:   Articles: Five-year outcomes of endosuture aneurysm repair in patients with short neck abdominal aortic aneurysm from the ANCHOR registry by Arko et al Sandwich thoracic branch endoprosthesis technique for endovascular repair of thoracic aortic aneurysm with aberrant right subclavian artery by Fleischman and Han et al   Show Guests: Dr. Arko is the Chief of Vascular and Endovascular Surgery with Atrium Health, Siverling Endowed Chair of vascular surgery clinical professor at Wake Forest University, and  co-director of Center for Aortic Disease at Sanger Heart and Vascular Institute. Dr. Sukgu Han is an Associate Professor of Surgery and Program Director for the residency/fellowship in the Division of Vascular Surgery and Endovascular Therapy at Keck School of Medicine of USC. He is also the Co-Director of the Comprehensive Aortic Center at Keck Hospital of USC.  Dr Fernando Fleischman is a cardiothoracic surgeon with extensive aortic expertise at Keck Hospital of USC. He is an Associate Professor of Surgery and Associate Program Director of cardiac surgery at USC. He is also the Co-Director of the Comprehensive Aortic Center.     Follow us @audiblebleeding Learn more about us at https://www.audiblebleeding.com/about-1/ and provide us with your feedback with our listener survey.

This episode features Alisa Starbuck, President of Brenner Children's Hospital, Atrium Health Wake Forest Baptist. Here she discusses her career journey, key insights about the hospital, potential roadblocks that leaders may encounter while striving for the best outcomes for children, and more.